9th Annual Biomarkers Congress

Genomics: GlaxoSmithKline

Total Score People Score Events Score
15 15 12
Date Event Presentation Speakers
May 31, 2013 ASCO Annual Meeting 2013 Special Session Catherine Wang
April 6, 2013 AACR Annual Meetings From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 2: Targeting Epigenetics: An Epicenter of Oncology Drug Discovery? Chairperson: Ho Man Chan, Novartis Institutes for BioMedical Research, Cambridge, MA Dashyant Dhanak
From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 4: Oncology Drug Discovery and Development: Combination Therapies Chairperson: Tona M. Gilmer, GlaxoSmithKline, Research Triangle Park, NC Tona M Gilmer, Axel Hoos
May 10, 2010 The New Science of Ageing Drug discovery for a broadspectrum, preventative medicine for ageing P Vallance
September 23, 2009 TRACK 4: Bridging Silos in Biomarker Development : Third Annual Biomarker Data Analysis An Effective Framework for Omic Data Analysis Jie J. Cheng
June 8, 2009 Genotyping Tools KEYNOTE PRESENTATION Allen Roses
February 3, 2009 Ramanbhai Foundation 4th International Symposium ---Ramanbhai Foundation 4th International Symposium--- “Advances in Cardiometabolic Research - Basic Science and Clinical Aspects” “Application of large-scale genetics to support drug discovery and development in the cardio-metabolic area” Vincent Mooser
January 26, 2009 Biomarker Assay Development Development and Integration of Biomarkers into Clinically Useful Diagnostics Anne Marie Martin
November 12, 2008 Third Annual Post-Approval Drug Safety Strategies: Best Practices to Mitigate Risks throughout the Product's Life Cycle Genomics Role in Safety: Moving from Observation to Prediction & Leveraging New Tools and Thinking Dan Burns
November 4, 2007 AACR Centennial Conference: Translational Cancer Medicine Concurrent Session 1: Clinical Pharmacogenetics: Assessing Global Diversity Eric C Lai
Concurrent Session 3: Hereditary Cancers Richard WOOSTER
October 15, 2007 2nd Annual Innovations in Clinical Trials: Implementations of Biomarkers (Oct15-16) BIOIMAGING FOR MONITORING RESPONSE TO THERAPY, DOSE SELECTION, ASSESSING MOLECULAR ACTIVITY AND RECEPTOR OCCUPANCY (08:00-13:30) Robert A. Comley
PET Receptor Occupancy - Accelerating Drug Development by Non-Invasive Measurement of Drug Action Early in the Development Pipeline (09:05-09:35) Robert A. Comley
September 30, 2007 Bridging Pharma and IT - Leveraging Information Technology to Improve Productivity (Sep30-Oct2) BRIDGING CLINICAL AND IT (10:45-15:15) Dongzhou J. Liu
BRIDGING CLINICAL AND IT: Practical Applications of Modeling and Simulation in Clinical Studies(11:30-12:30) Dongzhou J. Liu
September 24, 2007 High-Content Analysis Europe: High content Cellular Assays for compound screening and Pahtway Analysis (Sep 24-26) HCA for Mechanism-of-Action Studies: Use of the BD Pathway in CNS Drug Discovery to Determine Mechanisms of Compound Action in Primary Neuronal Cultures (16:00-16:30) Claire Scott
HCA for Mechanism-of-Action Studies (16:00-18:00) Claire Scott
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.